184 related articles for article (PubMed ID: 36304506)
1. Efficacy and Safety of Aspirin for Prevention of Hepatocellular Carcinoma: An Updated Meta-analysis.
Yan LJ; Yao SY; Li HC; Meng GX; Liu KX; Ding ZN; Hong JG; Chen ZQ; Dong ZR; Li T
J Clin Transl Hepatol; 2022 Oct; 10(5):835-846. PubMed ID: 36304506
[TBL] [Abstract][Full Text] [Related]
2. Does aspirin reduce the incidence, recurrence, and mortality of hepatocellular carcinoma? A GRADE-assessed systematic review and dose-response meta-analysis.
Ma S; Qu G; Sun C; Liu H; Jiang Y; Li N; Wu B; Gao J; Feng L; Xie P; Xia W; Kim NH; Lowe S; Bentley R; Zhu Y; Zhou Q; Sun Y
Eur J Clin Pharmacol; 2023 Jan; 79(1):39-61. PubMed ID: 36334108
[TBL] [Abstract][Full Text] [Related]
3. Aspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Memel ZN; Arvind A; Moninuola O; Philpotts L; Chung RT; Corey KE; Simon TG
Hepatol Commun; 2021 Jan; 5(1):133-143. PubMed ID: 33437907
[TBL] [Abstract][Full Text] [Related]
4. Association Between Aspirin Use and Risk of Hepatocellular Carcinoma.
Simon TG; Ma Y; Ludvigsson JF; Chong DQ; Giovannucci EL; Fuchs CS; Meyerhardt JA; Corey KE; Chung RT; Zhang X; Chan AT
JAMA Oncol; 2018 Dec; 4(12):1683-1690. PubMed ID: 30286235
[TBL] [Abstract][Full Text] [Related]
5. Regular Aspirin Use Is Associated with a Reduced Risk of Hepatocellular Carcinoma (HCC) in Chronic Liver Disease: a Systematic Review and Meta-analysis.
Tan JL; Sidhu-Brar S; Woodman R; Chinnaratha MA
J Gastrointest Cancer; 2023 Jun; 54(2):325-331. PubMed ID: 35717551
[TBL] [Abstract][Full Text] [Related]
6. Aspirin for the prevention of hepatocellular carcinoma: an updated meta-analysis with particular focus on patients with chronic liver disease.
Yi M; Feng X; Peng W; Teng F; Tang Y; Chen Z
Eur J Clin Pharmacol; 2022 Apr; 78(4):647-656. PubMed ID: 35032181
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Aspirin Use on Incident Hepatocellular Carcinoma-An Updated Systematic Review and Meta-Analysis.
Abdelmalak J; Tan N; Con D; Eslick G; Majeed A; Kemp W; Roberts SK
Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444628
[TBL] [Abstract][Full Text] [Related]
8. Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants.
Wang S; Yu Y; Ryan PM; Dang M; Clark C; Kontogiannis V; Rahmani J; Varkaneh HK; Salehisahlabadi A; Day AS; Zhang Y
Pharmacol Res; 2020 Jan; 151():104585. PubMed ID: 31816436
[TBL] [Abstract][Full Text] [Related]
9. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.
Sutcliffe P; Connock M; Gurung T; Freeman K; Johnson S; Kandala NB; Grove A; Gurung B; Morrow S; Clarke A
Health Technol Assess; 2013 Sep; 17(43):1-253. PubMed ID: 24074752
[TBL] [Abstract][Full Text] [Related]
10. The relationship between aspirin consumption and hepatocellular carcinoma: a systematic review and meta-analysis.
Wang S; Zuo L; Lin Z; Yang Z; Chen R; Xu Y
Eur J Med Res; 2023 Jul; 28(1):226. PubMed ID: 37422691
[TBL] [Abstract][Full Text] [Related]
11. Systematic Review and Meta-analysis: Association of Aspirin With Incidence of Hepatocellular Carcinoma.
Zhou X; Zhang T; Sun Y; Li C; Ding X; Zhu Y; Li L; Fan Z
Front Pharmacol; 2022; 13():764854. PubMed ID: 35300300
[No Abstract] [Full Text] [Related]
12. Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults.
Hwang IC; Chang J; Kim K; Park SM
Sci Rep; 2018 Mar; 8(1):4968. PubMed ID: 29563592
[TBL] [Abstract][Full Text] [Related]
13. Influence of aspirin use on clinical outcomes of patients with hepatocellular carcinoma: a meta-analysis.
Li X; Yu Y; Liu L
Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101545. PubMed ID: 33067170
[TBL] [Abstract][Full Text] [Related]
14. The effects of nonsteroidal anti-inflammatory drugs in the incident and recurrent risk of hepatocellular carcinoma: a meta-analysis.
Pang Q; Jin H; Qu K; Man Z; Wang Y; Yang S; Zhou L; Liu H
Onco Targets Ther; 2017; 10():4645-4656. PubMed ID: 29033583
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal anti-inflammatory drugs, especially aspirin, are linked to lower risk and better survival of hepatocellular carcinoma: a meta-analysis.
Tao Y; Li Y; Liu X; Deng Q; Yu Y; Yang Z
Cancer Manag Res; 2018; 10():2695-2709. PubMed ID: 30147368
[TBL] [Abstract][Full Text] [Related]
16. Daily Aspirin Reduced the Incidence of Hepatocellular Carcinoma and Overall Mortality in Patients with Cirrhosis.
Lee CH; Hsu CY; Yen TH; Wu TH; Yu MC; Hsieh SY
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296908
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
